These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23966476)

  • 1. Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report.
    Muller G
    Int J Pharm Compd; 2009; 13(3):220-1. PubMed ID: 23966476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
    Woodall R; Arnold JJ; McKay D; Asbill CS
    Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of promethazine in a topical pluronic lecithin organogel: a pilot study.
    Glisson JK; Wood RL; Kyle PB; Cleary JD
    Int J Pharm Compd; 2005; 9(3):242-6. PubMed ID: 23924984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroparesis-associated refractory nausea treated with aprepitant.
    Fahler J; Wall GC; Leman BI
    Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
    Bassani AS; Banov D; Lehman PA
    Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiological perspective for utility or futility of alcohol-based hand rub gel against nausea-vomiting: is it P-6 acupoint or transnasal aroma?
    Gupta D; Mazumdar A; Stellini M
    Am J Hosp Palliat Care; 2014 Sep; 31(6):608-10. PubMed ID: 23921290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies.
    Gan TJ; Candiotti KA; Klein SM; Rodriguez Y; Nielsen KC; White WD; Habib AS
    Can J Anaesth; 2009 Nov; 56(11):829-36. PubMed ID: 19730966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities.
    Zur E
    Int J Pharm Compd; 2013; 17(2):113-23. PubMed ID: 23696171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting.
    Mayhall EA; Gray R; Lopes V; Matteson KA
    Am J Emerg Med; 2015 Jul; 33(7):882-6. PubMed ID: 25921968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report.
    Mantovani G; Curreli L; Macciò A; Massa E; Massa D; Mulas C; Succu G; Contu P
    Anticancer Res; 1999; 19(4C):3495-502. PubMed ID: 10629642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The initial examination of the efficacy of low-dose promethazine for the treatment of nausea and vomiting in the hospitalized elderly.
    McClintock GH; LaReau RM; Watcharotone K; DeMaagd G
    Geriatr Nurs; 2010; 31(2):115-22. PubMed ID: 20381712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial.
    Braude D; Crandall C
    Acad Emerg Med; 2008 Mar; 15(3):209-15. PubMed ID: 18304050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient.
    Moon RB
    Int J Pharm Compd; 2006; 10(2):95-8. PubMed ID: 23974181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
    Bleicher J; Bhaskara A; Huyck T; Constantino S; Bardia A; Loprinzi CL; Silberstein PT
    J Support Oncol; 2008 Jan; 6(1):27-32. PubMed ID: 18257398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post discharge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis.
    Parlow JL; Meikle AT; van Vlymen J; Avery N
    Can J Anaesth; 1999 Aug; 46(8):719-24. PubMed ID: 10451129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the management of nausea and vomiting caused by antineoplastic agents.
    Merrifield KR; Chaffee BJ
    Clin Pharm; 1989 Mar; 8(3):187-99. PubMed ID: 2650957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.